UPR Overzicht aandelen
Uniphar plc is als gediversifieerd bedrijf actief in de gezondheidszorg in de Republiek Ierland, het Verenigd Koninkrijk, Nederland en internationaal. Meer informatie
Sneeuwvlok Score | |
---|---|
Waardering | 3/6 |
Toekomstige groei | 3/6 |
Prestaties in het verleden | 2/6 |
Financiële gezondheid | 4/6 |
Dividenden | 0/6 |
Beloningen
Risicoanalyse
Uniphar plc Concurrenten
Prijsgeschiedenis en prestaties
Historische aandelenkoersen | |
---|---|
Huidige aandelenkoers | €2.09 |
52 Week Hoogtepunt | €3.00 |
52 Week Laag | €1.97 |
Bèta | 0.79 |
11 maand verandering | -18.24% |
3 maanden verandering | -22.35% |
1 Jaar Verandering | -4.79% |
33 jaar verandering | -52.29% |
5 jaar verandering | 68.15% |
Verandering sinds IPO | 78.21% |
Recent nieuws en updates
The Price Is Right For Uniphar plc (ISE:UPR)
Nov 16Analysts Are Updating Their Uniphar plc (ISE:UPR) Estimates After Its Half-Year Results
Sep 06Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Recent updates
The Price Is Right For Uniphar plc (ISE:UPR)
Nov 16Analysts Are Updating Their Uniphar plc (ISE:UPR) Estimates After Its Half-Year Results
Sep 06Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Investors Met With Slowing Returns on Capital At Uniphar (ISE:UPR)
Jan 31Uniphar plc's (ISE:UPR) 25% Jump Shows Its Popularity With Investors
Dec 18These 4 Measures Indicate That Uniphar (ISE:UPR) Is Using Debt Reasonably Well
Nov 18The Returns At Uniphar (ISE:UPR) Aren't Growing
Sep 20Uniphar (ISE:UPR) Is Experiencing Growth In Returns On Capital
May 12The Uniphar plc (ISE:UPR) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 03Estimating The Intrinsic Value Of Uniphar plc (ISE:UPR)
Dec 16Here's Why We Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Nov 24An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 45% Undervalued
Aug 01What Does Uniphar plc's (ISE:UPR) Share Price Indicate?
Jul 20Some Investors May Be Worried About Uniphar's (ISE:UPR) Returns On Capital
May 27An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 33% Undervalued
Apr 29Uniphar (ISE:UPR) Seems To Use Debt Quite Sensibly
Apr 02Here's Why I Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Mar 18Uniphar (ISE:UPR) Might Be Having Difficulty Using Its Capital Effectively
Feb 13Is Uniphar (ISE:UPR) A Risky Investment?
Dec 23Here's Why I Think Uniphar (ISE:UPR) Is An Interesting Stock
Oct 30Uniphar's (ISE:UPR) Returns On Capital Not Reflecting Well On The Business
May 14Uniphar (ISE:UPR) Has A Pretty Healthy Balance Sheet
Mar 10Does Uniphar's (ISE:UPR) Share Price Gain of 83% Match Its Business Performance?
Feb 23Will The ROCE Trend At Uniphar (ISE:UPR) Continue?
Feb 02Is Weakness In Uniphar plc (ISE:UPR) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Jan 15Trade Alert: The CEO & Executive Director Of Uniphar plc (ISE:UPR), Gerard Rabbette, Has Just Spent €900k Buying 4.2% More Shares
Dec 24Do Institutions Own Uniphar plc (ISE:UPR) Shares?
Dec 23Is Uniphar (ISE:UPR) Using Too Much Debt?
Dec 03Uniphar (ISE:UPR) Shareholders Have Enjoyed A 91% Share Price Gain
Nov 18Rendement voor aandeelhouders
UPR | IE Healthcare | IE Markt | |
---|---|---|---|
7D | -0.2% | -1.0% | -0.5% |
1Y | -4.8% | 5.3% | 8.7% |
Rendement versus industrie: UPR presteerde slechter dan de Irish Healthcare -sector, die het afgelopen jaar een rendement van 5.3 % opleverde.
Rendement versus markt: UPR presteerde slechter dan Irish Market, dat het afgelopen jaar een rendement van 8.7 % opleverde.
Prijsvolatiliteit
UPR volatility | |
---|---|
UPR Average Weekly Movement | 3.9% |
Healthcare Industry Average Movement | 4.1% |
Market Average Movement | 3.8% |
10% most volatile stocks in IE Market | 6.1% |
10% least volatile stocks in IE Market | 2.4% |
Stabiele aandelenkoers: UPR heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van UPR is het afgelopen jaar stabiel geweest.
Over het bedrijf
Opgericht | Werknemers | CEO | Website |
---|---|---|---|
1967 | 3,000 | Ger Rabbette | www.uniphar.ie |
Uniphar plc is als gediversifieerd bedrijf actief in de gezondheidszorg in de Republiek Ierland, het Verenigd Koninkrijk, Nederland en internationaal. Het bedrijf is actief via drie divisies: Medtech, Pharma en Supply Chain & Retail. De divisie Medtech biedt uitbestede verkoop-, marketing-, distributie- en ondersteuningsdiensten aan fabrikanten van medische hulpmiddelen.
Uniphar plc Samenvatting
UPR fundamentele statistieken | |
---|---|
Marktkapitalisatie | €562.41m |
Inkomsten(TTM) | €45.17m |
Inkomsten(TTM) | €2.68b |
12.6x
Koers/Winstverhouding0.2x
P/S-verhoudingIs UPR overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
UPR resultatenrekening (TTM) | |
---|---|
Inkomsten | €2.68b |
Kosten van inkomsten | €2.27b |
Brutowinst | €408.69m |
Overige uitgaven | €363.52m |
Inkomsten | €45.17m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
Winst per aandeel (EPS) | 0.17 |
Brutomarge | 15.24% |
Nettowinstmarge | 1.68% |
Schuld/Eigen Vermogen Verhouding | 68.5% |
Hoe presteerde UPR op de lange termijn?
Bekijk historische prestaties en vergelijking